peripheral blood mononuclear cells (ATCC)
Structured Review

Peripheral Blood Mononuclear Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 893 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/peripheral blood mononuclear cells/product/ATCC
Average 99 stars, based on 893 article reviews
Images
1) Product Images from "Considerations for the use of targeted fluorescence contrast agents to detect circulating cancer cell populations with diffuse in vivo flow cytometry"
Article Title: Considerations for the use of targeted fluorescence contrast agents to detect circulating cancer cell populations with diffuse in vivo flow cytometry
Journal: Journal of Biomedical Optics
doi: 10.1117/1.JBO.31.2.027001
Figure Legend Snippet: Flow cytometry analysis of targeted contrast agent-labeled cancer cells and peripheral blood mononuclear cells (PBMCs). Suspensions of 1:1000 IGROV-1 ovarian cancer cells to PBMCs were incubated (a) without and (b) with OTL38. (c) Different FR expressing cancer cell lines and PBMCs incubated with OTL38 compared with unlabeled PBMCs, cells, and reference μspheres (JGLI). Labeled cell threshold (black line) and NIR-DiFC detection threshold (red line) are shown, and percentages of cell populations above the respective threshold are indicated in the same color. Suspensions of 1:1000 LLC lung cancer to PBMCs were incubated (d) without and (e) with VGT-309. (f) Different cathepsin-expressing cancer cell lines and PBMCs incubated with VGT-309 compared with unlabeled PBMCs, cells, and reference μ spheres (JGLI). Labeled cell threshold (black line) and NIR-DiFC detection threshold (red line) are shown, and percentages of cell populations above the respective threshold are indicated in the same color.
Techniques Used: Flow Cytometry, Labeling, Incubation, Expressing
Figure Legend Snippet: Flow cytometry analysis of targeted contrast agent-labeled cancer cells and PBMCs. Suspensions of 1:1000 LNCaP prostate cancer cells to PBMCs were incubated (a) without and (b) with PSMA-02. (c) Different PSMA-expressing cancer cell lines and PBMCs incubated with PSMA-02 compared with unlabeled PBMCs, cells, and reference μ spheres (JGLI). Labeled cell threshold (black line) and Red-NIR-DiFC detection threshold (green line) are shown, and percentages of cell populations above the respective threshold are indicated in the same color. Suspensions of 1:1000 LNCaP prostate cancer to PBMCs were incubated (d) without and (e) with PSMA-04. (f) Different PSMA-expressing cancer cell lines and PBMCs incubated with PSMA-04 compared with unlabeled PBMCs, cells, and reference μ spheres (JGLI). Labeled cell threshold (black line) and Red-NIR-DiFC detection threshold (green line) are shown, and percentages of cell populations above the respective threshold are indicated in the same color.
Techniques Used: Flow Cytometry, Labeling, Incubation, Expressing
